Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2S,6S,11R,25R,28R)-28-((4-(di-tert-butylfluorosilyl)benzamido)methyl)-4,9,16,19,27,30-hexaoxo-1-(1H-tetrazol-5-yl)-32-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)-3,5,10,15,20,26,29-heptaazadotriacontane-2,6,11,25,32-pentacarboxylic acid
ID: ALA5270524
Chembl Id: CHEMBL5270524
Max Phase: Preclinical
Molecular Formula: C61H95FN16O23Si
Molecular Weight: 1467.60
Associated Items: